Organizers

Formed in 2005, the Sanford Consortium is a nonprofit organization that marshals the intellectual resources of four world-leaders in life sciences research: the Sanford-Burnham Medical Research Institute, the Salk Institute for Biological Studies, The Scripps Research Institute and the University of California, San Diego. Using the collective strength of its members, the Consortium’s research program is focused on developing tools and technologies to hasten the pace of stem cell research progress and to discover and develop diagnostics, therapies and cures to relieve human suffering from chronic disease and injury. The Consortium was originally assembled as the San Diego Consortium for Regenerative Medicine, but renamed in September 2008 after a naming donation from T. Denny Sanford.
 
The California Institute for Regenerative Medicine is accelerating the development of new therapies for chronic disease and injury by funding stem cell research programs throughout California. We were established in 2004 after Californians passed Proposition 71, the California Stem Cell Research and Cures Initiative. The statewide ballot measure, which provided $3 billion in funding for stem cell research at California universities and research institutions, called for the establishment of a new state agency to make grants and provide loans for stem cell research, research facilities and other vital research opportunities. The mission of CIRM is to support and advance stem cell research and regenerative medicine under the highest ethical and medical standards for the discovery and development of cures, therapies, diagnostics and research technologies to relieve human suffering from chronic disease and injury.


The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based non-profit organization whose mission is to educate key policy makers about the potential of regenerative medicine and to advocate for favorable public policies—funding, regulatory, reimbursement and others—to facilitate advances in the field. ARM currently has over 80 members comprised of regenerative medicine and large pharmaceutical companies, patient advocacy groups, non-profit research and educational institutions, and investors.